654 related articles for article (PubMed ID: 17382885)
1. Programmed anuclear cell death delimits platelet life span.
Mason KD; Carpinelli MR; Fletcher JI; Collinge JE; Hilton AA; Ellis S; Kelly PN; Ekert PG; Metcalf D; Roberts AW; Huang DC; Kile BT
Cell; 2007 Mar; 128(6):1173-86. PubMed ID: 17382885
[TBL] [Abstract][Full Text] [Related]
2. Regulation of stress-induced nuclear protein redistribution: a new function of Bax and Bak uncoupled from Bcl-x(L).
Lindenboim L; Blacher E; Borner C; Stein R
Cell Death Differ; 2010 Feb; 17(2):346-59. PubMed ID: 19816507
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 family proteins are essential for platelet survival.
Zhang H; Nimmer PM; Tahir SK; Chen J; Fryer RM; Hahn KR; Iciek LA; Morgan SJ; Nasarre MC; Nelson R; Preusser LC; Reinhart GA; Smith ML; Rosenberg SH; Elmore SW; Tse C
Cell Death Differ; 2007 May; 14(5):943-51. PubMed ID: 17205078
[TBL] [Abstract][Full Text] [Related]
4. Targeting multiple arms of the apoptotic regulatory machinery.
Dai Y; Grant S
Cancer Res; 2007 Apr; 67(7):2908-11. PubMed ID: 17409392
[TBL] [Abstract][Full Text] [Related]
5. Platelet life span and apoptosis.
Josefsson EC; White MJ; Dowling MR; Kile BT
Methods Mol Biol; 2012; 788():59-71. PubMed ID: 22130700
[TBL] [Abstract][Full Text] [Related]
6. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
7. Oligomerization of BH4-truncated Bcl-x(L) in solution.
Wang Y; Cao R; Liu D; Chervin A; Yuan J; An J; Huang Z
Biochem Biophys Res Commun; 2007 Oct; 361(4):1006-11. PubMed ID: 17692289
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of benzoylurea-derived alpha-helix mimetics targeting the Bcl-x(L)/Bak binding interface.
Rodriguez JM; Ross NT; Katt WP; Dhar D; Lee GI; Hamilton AD
ChemMedChem; 2009 Apr; 4(4):649-56. PubMed ID: 19330783
[TBL] [Abstract][Full Text] [Related]
9. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
[TBL] [Abstract][Full Text] [Related]
10. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death.
Tajeddine N; Galluzzi L; Kepp O; Hangen E; Morselli E; Senovilla L; Araujo N; Pinna G; Larochette N; Zamzami N; Modjtahedi N; Harel-Bellan A; Kroemer G
Oncogene; 2008 Jul; 27(30):4221-32. PubMed ID: 18362892
[TBL] [Abstract][Full Text] [Related]
11. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets.
Schoenwaelder SM; Jarman KE; Gardiner EE; Hua M; Qiao J; White MJ; Josefsson EC; Alwis I; Ono A; Willcox A; Andrews RK; Mason KD; Salem HH; Huang DC; Kile BT; Roberts AW; Jackson SP
Blood; 2011 Aug; 118(6):1663-74. PubMed ID: 21673344
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis.
Rudner J; Elsaesser SJ; Müller AC; Belka C; Jendrossek V
Biochem Pharmacol; 2010 Jan; 79(1):10-20. PubMed ID: 19665451
[TBL] [Abstract][Full Text] [Related]
13. Physiological restraint of Bak by Bcl-xL is essential for cell survival.
Lee EF; Grabow S; Chappaz S; Dewson G; Hockings C; Kluck RM; Debrincat MA; Gray DH; Witkowski MT; Evangelista M; Pettikiriarachchi A; Bouillet P; Lane RM; Czabotar PE; Colman PM; Smith BJ; Kile BT; Fairlie WD
Genes Dev; 2016 May; 30(10):1240-50. PubMed ID: 27198225
[TBL] [Abstract][Full Text] [Related]
14. [Progress in small-molecule inhibitors of Bcl-2 family proteins].
Tang Y; Zhang DY; Wu XM
Yao Xue Xue Bao; 2008 Jul; 43(7):669-77. PubMed ID: 18819468
[TBL] [Abstract][Full Text] [Related]
15. Importance of Bak for celecoxib-induced apoptosis.
Müller AC; Handrick R; Elsaesser SJ; Rudner J; Henke G; Ganswindt U; Belka C; Jendrossek V
Biochem Pharmacol; 2008 Oct; 76(9):1082-96. PubMed ID: 18778687
[TBL] [Abstract][Full Text] [Related]
16. Suppression of apoptosis, crypt hyperplasia, and altered differentiation in the colonic epithelia of bak-null mice.
Duckworth CA; Pritchard DM
Gastroenterology; 2009 Mar; 136(3):943-52. PubMed ID: 19185578
[TBL] [Abstract][Full Text] [Related]
17. miR-326 targets antiapoptotic Bcl-xL and mediates apoptosis in human platelets.
Yu S; Huang H; Deng G; Xie Z; Ye Y; Guo R; Cai X; Hong J; Qian D; Zhou X; Tao Z; Chen B; Li Q
PLoS One; 2015; 10(4):e0122784. PubMed ID: 25875481
[TBL] [Abstract][Full Text] [Related]
18. The C-terminal helix of Bcl-x(L) mediates Bax retrotranslocation from the mitochondria.
Todt F; Cakir Z; Reichenbach F; Youle RJ; Edlich F
Cell Death Differ; 2013 Feb; 20(2):333-42. PubMed ID: 23079612
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia.
Kuroda J; Kimura S; Strasser A; Andreeff M; O'Reilly LA; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Tabe Y; Taniwaki M; Maekawa T
Cell Death Differ; 2007 Sep; 14(9):1667-77. PubMed ID: 17510658
[TBL] [Abstract][Full Text] [Related]
20. Loss of PUMA (BBC3) does not prevent thrombocytopenia caused by the loss of BCL-XL (BCL2L1).
Delbridge AR; Chappaz S; Ritchie ME; Kile BT; Strasser A; Grabow S
Br J Haematol; 2016 Sep; 174(6):962-9. PubMed ID: 27221652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
